Notes - Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7711657

Concept 2018-03-01 to
2019-02-28
2018-03-01 to
2019-02-28
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period

※2 (前連結会計年度)

   一般管理費に含まれる研究開発費は15,076百万円です。

なお、製造費用に含まれる研究開発費はありません。

   (当連結会計年度) 

   一般管理費に含まれる研究開発費は13,032百万円です。

なお、製造費用に含まれる研究開発費はありません。

Notes regarding impairment losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.